Vitamin D: The Iceberg Nutrient

Journal of Renal Nutrition

Volumn 21, Issue 2, 2011, Pages 134-139

  Armas, Laura A G ^a   Heaney, Robert P ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; DRUG DERIVATIVE; ERGOCALCIFEROL; PARATHYROID HORMONE; VITAMIN D;

CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; HOMEOSTASIS; HUMAN; METABOLISM; NEOPLASM; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; VITAMIN D DEFICIENCY;

CALCITRIOL; CALCIUM; CARDIOVASCULAR DISEASES; ERGOCALCIFEROLS; HOMEOSTASIS; HUMANS; KIDNEY FAILURE, CHRONIC; NEOPLASMS; PARATHYROID HORMONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79951577826     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2010.09.002     Document Type: Review

References (64)

1. Haney E.M., Stadler D., Bliziotes M.M. Vitamin D insufficiency in internal medicine residents. Calcif Tissue Int 2005, 76:11-16.
2. MacFarlane G.D., Sackrison J.L., Body J.J., et al. Hypovitaminosis D in a normal, apparently healthy urban European population. J Steroid Biochem Mol Biol 2004, 89-90:621-622.
3. Levin A., Bakris G.L., Molitch M., et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007, 71:31-38.
4. Del Valle E., Negri A.L., Aguirre C., et al. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int 2007, 11:315-321.
5. Saab G., Young D.O., Gincherman Y., et al. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract 2007, 105:c132-c138.
6. Holick M. Vitamin D deficiency. N Engl J Med (USA) 2007, 357:266-281.
7. Armas L.A., Hollis B.W., Heaney R.P. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004, 89:5387-5391.
8. Trang H.M., Cole D.E., Rubin L.A., et al. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998, 68:854-858.
9. Zisman A., Hristova M., Ho L.T., et al. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol 2007, 27:36-43.
10. Pesenson A., Maski M. Prevalence of 25-OH vitamin D (25-OH) deficiency in patients (Pts) with chronic kidney disease (CKD) and effects of correction following KDOQI guidelines. J Am Soc Nephrol 2006, (Suppl 1). (abstr) 17:694A.
11. Holick M. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006, 81:353-373.
12. Armas L.A.G. Vitamin D and the immune system. Int J Clin Rheumatol 2009, 4:89-103.
13. Heaney R. Vitamin D and calcium interactions: functional outcomes. Am J Clin Nutr 2008, 88:541S-544S.
14. Heaney R. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004, 80:1706S-1709S.
15. Lambert P.W., Stern P.H., Avioli R.C., et al. Evidence for extrarenal production of 1 alpha, 25-dihydroxyvitamin D in man. J Clin Invest 1982, 69:722-725.
16. Jean G., Terrat J.C., Vane T., et al. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment. Nephron Clin Pract 2008, 110:c58-c65.
17. Bikle D., Halloran B., Riviere J. Production of 1,25 dihydroxyvitamin D3 by perfused pig skin. J Invest Dermatol 1994, 102:796-798.
18. DeVille J., Thorp M.L., Tobin L., et al. Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease. Nephrology 2006, 11:555-559.
19. Naves-Diaz M., Alvarez-Heernandez D., Passlick-Deetjen J., et al. Oral active vitamin D is associated with improved survival in hemodialysis patients. Kidney Int 2008, 74:1070-1078.
20. Teng M., Wolf M., Ofsthun M.N., et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005, 16:1115-1125.
21. Bishcoff-Ferrari H., Dietrich T., Orav E.J., et al. Positive association between 25-hydroxivitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004, 116:634-639.
22. Komaba H., Fukagawa M. FGF23-parathyroid interaction: implications in chronic kidney disease. Kidney Int 2010, 77:292-298.
23. Scragg R., Sowers M., Bell C. Third-National-Health-and-Nutrition-Examination-Survey: Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004, 27:2813-2818.
24. Bischoff-Ferrari H.A., Dietrich T., Orav E.J., et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged >60 y. Am J Clin Nutr 2004, 80:752-758.
25. Dietrich T., Joshipura K.J., Dawson-Hughes B., et al. Association between serum concentrations of 25-hydroxyvitamin D3 and periodontal disease in the US population. Am J Clin Nutr 2004, 80:108-113.
26. Holick M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004, 80:1678S-1688S.
27. Cross H.S. Extrarenal vitamin D hydroxylase expression and activity in normal and malignant cells: modification of expression by epigenetic mechanisms and dietary substances. Nutr Rev 2000, 65:S108-S112.
28. Rohan T. Epidemiological studies of vitamin D and breast cancer. Nutr Rev 2007, 65:S80-S83.
29. Garland C.F., Garland F.C., Gorham E.D., et al. The role of vitamin D in cancer prevention. Am J Public Health 2006, 96:252-261.
30. Garland C., Garland F. Do sunlight and vitamin D reduce the likelihood of colon cancer?. Int J Epidemiol 1980, 9:227-231.
31. Gorham E., Garland C., Garland F. Acid haze air pollution and breast and colon cancer in 20 Canadian cities. Can J Public Health 1989, 80:96-100.
32. Garland F., Garland C., Gorham E., et al. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 1990, 19:614-622.
33. Grant W.B. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002, 94:1867-1875.
34. Grant W., Garland C. The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 2006, 26:2687-2699.
35. Wactawski-Wende J., Kotchen J.M., Anderson G.L., et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006, 354:684-696.
36. Lappe J., Travers-Gustafson D., Davies K.M., et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007, 85:1586-1591.
37. Teng M., Wolf M., Lowrie E., et al. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol. N Engl J Med 2003, 349:446-456.
38. Wang L., Manson J.E., Song Y., et al. Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010, 152:315-323.
39. Kovesdy C., Ahmadzadeh S., Anderson J., et al. Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med 2008, 168:397-403.
40. Giovannucci E., Liu Y., Hollis B.W., et al. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008, 168:1174-1180.
41. Wang T.J., Pencina M.J., Booth S.L., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
42. Dobnig H., Pilz S., Scharnagl H., et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008, 168:1340-1349.
43. Pilz S., Dobnig H., Fischer J.E., et al. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 2008, 39:2611-2613.
44. Kilkkinen A., Knekt P., Ato A., et al. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 2009, 170:1032-1039.
45. Trivedi D.P., Doll R., Khaw K.T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial. BMJ 2003, 326:469.
46. Hsia J., Heiss G., Ren H., et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007, 115:846-854. Women's Health Initiative Investigators.
47. Prince R.L., Austin N., Devine A., et al. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med 2008, 168:103-108.
48. Reid I.R., Ames R., Mason B., et al. Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch Intern Med 2008, 168:2276-2282.
49. Andress D.L. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int 2006, 69:33-43.
50. United States Renal Data System Excerpts from the USRDS 2009 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 2010, 55:S1.
51. United States Renal Data System (USRDS) Survival, mortality, & causes of death. Am J Kidney Dis 2001, 38:S135.
52. Naqvi S.B., Collins A.J. Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis 2006, 13:199-204.
53. Liu P.T., Stenger S., Li H., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
54. Mahon B.D., Wittke S., Weaver V., et al. The targets of vitamin D depend on the differentiation and activation status of CD4-positive T cells. J Cell Biochem 2003, 89:922-932.
55. Raab W. Vitamin D-its bactericidal action. Chest 1946, 12:409-415.
56. Nursyam E.W., Amin Z., Rumende C.M. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006, 38:3-5.
57. Aloia J.F., Li-Ng M. RE: epidemic influenza and vitamin D. Epidemiol Infect 2007, 134:1129-1130.
58. Li-Ng M., Aloia J.F., Pollack S., et al. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect 2009, 137:1396-1404.
59. Urashima M., Segawa T., Okazaki M., et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010, 91:1255-1260.
60. Bischoff-Ferrari H., Dawson-Hughes B., Platz A., et al. Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Arch Intern Med 2010, 170:813-820.
61. Hathcock J.N., Shao A., Vieth R., et al. Risk assessment for vitamin D. Am J Clin Nutr 2007, 85:6-18.
62. Chandra P., Binongo J.N.G., Ziegler T.R., et al. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract 2008, 14:10-17.
63. Moe S., Saifullah A., LaClair R., et al. A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease. Clin J Am Soc Nephrol 2010, 5:299-306.
64. Oksa A., Spustova V., Krivosikova Z., et al. Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease. Kidney Blood Press Res 2008, 31:322-329.